Forbes
@forbes·2.1M subscribers·11.3K videos
Isis Chief Says Safety Concerns Could Slow His Competitors
Posted
January 9, 2012
Views
1,225
January 9, 2012
1,225
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:57Now PlayingStan Crooke says the FDA could delay the development of cholesterol medicines that target the PCSK9 gene.
Developers of PCSK9 drugs say they do not share Crooke's concern. Regeneron confirmed the receipt of a letter but said the concerns were "completely standard and typical of the drug development process." Amgen said its interactions with the FDA have been "productive and positive." The FDA said it cannot comment on products under review, and Pfizer did not return calls requesting comment.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
